THE NEXT CHAPTER OF BIOTECHNOLOGY
Maryland is already a national leader in biotechnology and life sciences. The next opportunity is to extend that strength into bioindustrial manufacturing—using biology not only to develop medicines, but to make agricultural products, food ingredients, materials, chemicals, enzymes and other products the economy uses every day.
For decades, biotechnology has transformed medicine. Now biology is also transforming how we make products.
Bioindustrial manufacturing uses microorganisms, cells, enzymes, fermentation and other biological processes to produce useful products at commercial scale.
This does not replace biopharma or life sciences. It expands the biotechnology economy alongside them.
Uses biology to improve human health.
Uses biology to make products.
ONE BROADER BIOTECHNOLOGY ECONOMY
Biological crop inputs, soil-health products, animal nutrition and agricultural technologies.
Proteins, fats, flavors and functional ingredients produced or improved through biological processes.
Biological catalysts that enable more efficient industrial processes.
Bio-based polymers, fibers, coatings, packaging and other materials.
Specialty and commodity chemicals produced through biological pathways.
Higher-value products made from agricultural residues, food-processing streams, wood residues and other biological resources.
Maryland and Delaware bring together an unusual combination of assets: a world-class biotechnology and research base, one of the country’s most productive agricultural regions, major universities, federal research capabilities, transportation infrastructure, access to major markets and an established life-sciences workforce.
The opportunity is to connect those strengths into a functioning bioindustrial economy.
BIOTECHNOLOGY • AGRICULTURE • RESEARCH • MANUFACTURING • MARKETS • WORKFORCE
Innovation alone does not create an industry. Companies need a connected pathway from discovery through development, scale-up, validation and manufacturing—and ultimately into the marketplace.
FEEDSTOCKS • WORKFORCE • CAPITAL • INFRASTRUCTURE • RESEARCH • COMMERCIALIZATION
Maryland and Delaware already have many of the individual pieces. The opportunity is to connect them so discoveries can become companies, companies can become manufacturers, and regional agriculture can participate in new markets.
Bioindustrial manufacturing creates a direct connection between biotechnology and agriculture. In many applications, the biological carbon used in manufacturing can come from crops, agricultural byproducts, food-processing streams, wood residues and other renewable biological resources.
That creates the potential for new markets for farmers and rural communities.
The goal is not simply to replace fossil carbon with biological carbon. It is to build supply chains that are economically viable, traceable and environmentally sustainable.
That means qualifying feedstocks to manufacturer specifications while protecting soil health, water, biodiversity and long-term agricultural productivity.
A technology that works in a university laboratory or startup bench experiment is not automatically ready to manufacture.
Companies must demonstrate that their process can work at larger scales, produce consistent results, meet specifications and make economic sense.
Without a bridge from laboratory discovery to manufacturing, promising technologies can leave the region—or never reach the market at all.
Pilot-scale infrastructure helps close that gap and gives companies a pathway from innovation toward commercial manufacturing.
New demand for crops, byproducts and specification-grade biological feedstocks.
Production, engineering, operations and technical career opportunities.
A pathway for promising companies to develop and scale within the region.
A stronger connection between biotechnology investment and agricultural communities.
Greater domestic capacity to manufacture strategically important products and materials.
Biological manufacturing pathways that can reduce dependence on fossil resources while protecting agricultural and natural systems.
The Delmarva Peninsula sits at the intersection of two powerful economies: the Mid-Atlantic biotechnology corridor and one of America’s most productive agricultural regions.
Connecting those strengths creates the possibility of a Bio Peninsula where biotechnology, agriculture and manufacturing reinforce one another.
The vision is not a single facility, company or project. It is a regional system in which discoveries can be developed, companies can scale, farmers can participate in new supply chains, workers can enter new careers, and biological products can ultimately be manufactured here.
F3 Tech is helping connect the commercialization pieces of this emerging ecosystem—working with companies, universities, agriculture, government, analytical partners and economic-development organizations.
From our existing development capabilities in Easton to regional feedstock initiatives and the pursuit of larger pilot-scale biomanufacturing infrastructure, the objective is the same: help biological innovation move toward manufacturing and market.
THE BIOINDUSTRIAL FUTURE SERIES
This page accompanies an ongoing series in The Spy exploring how biotechnology, agriculture and manufacturing are converging—and what that convergence could mean for Maryland’s Eastern Shore, Delaware and the broader region.
Maryland and Delaware do not need to choose between life sciences and bioindustrial manufacturing. The opportunity is to build on the region’s biotechnology strength and extend it into agriculture, food, materials, chemicals and manufacturing.
